Amgen's Imdelltra with AstraZeneca's Imfinzi improves survival in late-stage small-cell lung cancer trial
SentiSense · Published · Updated
AMGN and AstraZeneca said on September 8, 2026 that combining AstraZeneca's Imfinzi with Amgen's Imdelltra significantly improved over...
Sign in to read the full story. Free accounts include 20 full reads a month.
Powered by SentiSense - Intelligent Market Analysis